Home Dialysis News

New findings demonstrating positive outcomes related to seven days a week dialysis services were presented Nov. 4 at the American Society of Nephrology’s Kidney Week 2017 in New Orleans.  The research was conducted by a group of nephrologists from Centro Brasiliense de Nefrologia & Dialise (CBN&D), Brazil.

Baxter International Inc. highlighted new data from two studies presented at Kidney Week on its expanded hemodialysis (HDx) therapy enabled by the Theranova dialyzer. The studies were conducted by clinicians in the United Kingdom and Germany.

New Orleans - Daily home hemodialysis patients with a fistula had a higher risk of a first infection-related hospitalization (IH) than in-center hemodialysis patients with a fistula, according to an abstract presented by Eric D. Weinhandl, PhD, and Allan J. Collins, MD, from NxStage Medical Inc., at the American Society of Nephrology's Kidney Week 2017.

If we hope to be successful in a rapidly changing health care environment, dialysis providers can’t afford to maintain the status quo. “Successful” doesn’t just refer to financial stability; it also means providing good quality care for our patients.

Baxter International Inc. said it has enrolled the first patients in two new clinical trials for its dialyzer Theranova. The dialyzer is designed to enable expanded dialysis (HDx) and remove large molecular weight toxins in dialysis patients. It’s currently available in Europe, select markets in Latin America, the Middle East and Far East, as well as in Australia and New Zealand. In Colombia, Baxter initiated a second large multi-center, prospective, observational trial designed to understand the impact of removing large uremic toxins on survival and hospitalization for end-stage renal disease patients.

Baxter International Inc. is developing a peritoneal dialysis solution generation system that would produce sterile PD solutions in patients' homes. The company said it has received guidance from the the U.S. Food and Drug Administration clarifying the regulatory pathway for the system, which would use a small water filtration device and would be integrated with the Amia PD system.

Cardiovascular deaths from all causes among hemodialysis (HD) patients have decreased significantly, but sudden cardiac death rates remain high, according to research presented at the National Kidney Foundation's 2017 Spring Clinical Meetings.

ORLANDO, Fla. – Most patients with end-stage renal disease will start on some form of dialysis. But another option—making the decision to choose conservative care and forgo dialysis—doesn’t mean “doing nothing,” noted LaVonne Burrows, APRN, BC, CNN, during a presentation at the National Kidney Foundation’s Spring Clinical Meetings held here this week.

On April 6, Senate Finance Committee Chair Orrin Hatch, R-Utah, introduced the CHRONIC Care Act of 2017, S. 870. The bill is an updated version of legislation Hatch introduced in December 2016 and includes a section that would expand the ability of Medicare beneficiaries on home dialysis to receive required monthly clinical assessments using telehealth, beginning in 2019.

Pioneering nephrologist Frank A. Gotch, who used kinetic modeling to formulize the Kt/V measure for dialysis, died Feb. 28. He was 91.